IV metoclopramide Vs IV ketorolac in the treatment of acute primary headaches: A randomized clinical trial

Am J Emerg Med. 2022 Jun:56:358-359. doi: 10.1016/j.ajem.2021.09.068. Epub 2021 Oct 2.

Authors

Shahida S Chowdhury¹, Mariame Shaw², Ivan Berezowski², Ahmed Abdelmonem², Jigar Patel²

Affiliations

¹ International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC, United States. Electronic address: shahida.c3@gmail.com.
² International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC, United States.

PMID: 34654598
DOI: 10.1016/j.ajem.2021.09.068

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Acute Pain* / drug therapy
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Double-Blind Method
Headache / drug therapy
Humans
Ketorolac* / therapeutic use
Metoclopramide / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Metoclopramide
Ketorolac